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Abstract
Spinal cord injury (SCI) triggers a multitude of pathophysiological events that are tightly regulated by the expression levels
of specific genes. Recent studies suggest that changes in gene expression following neural injury can result from the
dysregulation of microRNAs, short non-coding RNA molecules that repress the translation of target mRNA. To understand
the mechanisms underlying gene alterations following SCI, we analyzed the microRNA expression patterns at different time
points following rat spinal cord injury. The microarray data reveal the induction of a specific microRNA expression pattern
following moderate contusive SCI that is characterized by a marked increase in the number of down-regulated microRNAs,
especially at 7 days after injury. MicroRNA downregulation is paralleled by mRNA upregulation, strongly suggesting that
microRNAs regulate transcriptional changes following injury. Bioinformatic analyses indicate that changes in microRNA
expression affect key processes in SCI physiopathology, including inflammation and apoptosis. MicroRNA expression
changes appear to be influenced by an invasion of immune cells at the injury area and, more importantly, by changes in
microRNA expression specific to spinal cord cells. Comparisons with previous data suggest that although microRNA
expression patterns in the spinal cord are broadly similar among vertebrates, the results of studies assessing SCI are much
less congruent and may depend on injury severity. The results of the present study demonstrate that moderate spinal cord
injury induces an extended microRNA downregulation paralleled by an increase in mRNA expression that affects key
processes in the pathophysiology of this injury.
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Introduction
Traumatic spinal cord injury SCI is characterized by a specific
pathophysiological response that can be divided into three phases.
The acute phase represents the initial trauma and affects the
neural tissue directly, inducing a state of spinal shock. The acute
phase is followed by a secondary phase that takes place over a time
course of minutes to weeks after the injury and exacerbates the
damage inflicted by the primary injury. The secondary phase
comprises several interrelated damage processes that include
vascular alterations, biochemical disturbances and cellular re-
sponses that lead to an inflammatory response and cell death. The
chronic phase occurs between days to years after the trauma and is
characterized by apoptosis, Wallerian degeneration and scarring
that establishes functional impairment [1,2]. Processes occurring
after SCI are associated with altered gene expression patterns;
there is a strong upregulation of genes related to inflammation and
cell death along with a downregulation of genes involved in cell
excitability and neurotransmission within the first hours after
injury. Upregulation of the genes involved in inflammation and
apoptosis persist during the first weeks, whereas genes regulating
cytoskeletal arrangement, myelin ensheathment and synapsis show
decreased expression, reflecting compromised tissue integrity.
However, genes coding for angiogenic, neuritogenic and growth
factors show increased expression, in an attempt to promote
survival and regeneration [1]. This alteration of gene expression
that is associated with processes triggered by SCI is thought to be
accompanied by the post-transcriptional regulation of these
modified gene networks. Among the known post-transcriptional
regulators, microRNAs have recently attracted much attention
due to their ability to inhibit mRNA translation. Nearly 750 of
these small (18–25 nucleotides), non-coding RNA sequences have
been identified in humans [3]. MicroRNAs are present in all
systems, including the CNS, where they are involved in the
regulation of nervous diseases and in neurotraumatic pathologies
such as Alzheimer’s, Parkinson’s, and Huntington’s diseases,
Tourette’s syndrome and schizophrenia [4]. Preliminary studies
using microarray analyses to examine microRNA expression
profiles post-SCI in mice [5] and rats [6] have confirmed
significant and common changes in the expression of several
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potential downstream targets for some of these [6].
In this study, we performed a detailed analysis combining the
use of microarrays, Q-PCR and several bioinformatic tools to
characterize the microRNA expression changes induced by spinal
cord contusion in a rat model. To deepen our understanding of the
evolution of microRNA expression patterns following SCI, we
examined microRNA expression at 3 different time points after
injury (1, 3, and 7 days) and compared the expression levels at
these times with those from untreated controls and surgical
controls (shams). Our results reveal that a progressive microRNA
underexpression occurs following SCI, and becomes particularly
significant 7 days after injury.
This temporal pattern is closely correlated with the increases in
mRNA expression observed 7 days after injury in previous studies
[7,8]. Moreover, a computational re-analysis of previous mRNA
expression data predicted some of the observed microRNA
expression changes, strongly suggesting a role for microRNA
regulation in the processes that occur post-SCI. Integration and
annotation of these data allow for the prediction of microRNA
regulation in different pathways such as inflammation, nervous
system development or cell death. Taken together, the data
presented here strongly suggest that microRNAs are involved in
different pathophysiological processes that are triggered after SCI,
suggesting that the modulation of microRNA expression may be a
promising therapeutic tool.
Results
Experimental spinal cord injury induces a motor
medullary paralysis of medium grade
Wistar rats received a moderate contusion (200 kdyne) at the
level of the 8th thoracic vertebra (T8) to produce a reproducible
spinal cord injury. Prior to sacrifice, injured rats were evaluated for
hind-limb locomotion using the Basso, Beattie and Bresnahan
locomotor rating scale (BBB scale) [9] and its subscore scale as
modified by McTigue and collaborators (2007) [10]. Individual
BBB scores and subscores were plotted as functions of the length of
time after injury. We observed that all groups presented
homogeneous values, and the means of the BBB scores agreed
with the moderate spinal cord injury values obtained in previous
studies [7,9,11] (Figure 1A, B). The injured animals presented
some degree of spontaneous recovery of motor function as the time
after injury progressed. An additional group of animals were used
to assess histopathology, and we observed that the injury size of the
area adjacent to the injury increased with the length of time post-
injury (Fig. 1C).
MicroRNA expression profiling of intact, sham, and
injured rat spinal cords
MicroRNA expression data were obtained after RNA samples
were hybridized to Exiqon miRCURY LNA microRNA v.11
microarrays carrying probes for 1,773 unique microRNA
sequences. This microarray set comprises all human, mouse, and
rat microRNAs that are included in the miRBase database v. 11.0
(http://www.mirbase.org), in addition to some viral sequences and
novel human mature sequences identified by Exiqon (hsa-miRPlus
probes). RNA from the spinal cord at the T8 level was extracted 1,
3, and 7 days after either laminectomy and contusion injury (lesion
animals) or after laminectomy without contusion (sham animals).
An additional group of animals that did not receive surgery was
included as a representation of naive conditions (control animals).
RNA was obtained from 5 animals in each of the 7 resulting
groups. The processing and normalization of the hybridization
data were performed using the variance stabilization normaliza-
tion (VSN) methodology to obtain microRNA expression profiles
for the 35 samples (Figure 2). The raw and the VSN-transformed
data are available at the GEO database (http://www.ncbi.nlm.
nih.gov/geo, last accessed in July 2011), under the GSE19890
accession code. On average, approximately 500 microRNAs were
detected at levels above background in each sample, correspond-
ing to an average of 28% of the microRNA probes included in the
array. In total, microRNA expression was detected by 3,643 out of
the 7,091 total microarray probes, corresponding to 901
microRNAs and representing roughly 51% of the microRNAs
under investigation, including 268 rat sequences (77% of the 349
rat probes included in the array). Of the 901 detected microRNAs,
463 showed variable expression levels across samples, with an
interquartile range above 0.5. An Excel file including all matrices
and processing information is available as supplementary material
(file S1).
Principal components analysis (PCA) and unsupervised, hierar-
chical clustering analysis (HCL) of the samples and the
hybridization levels of the 463 microRNAs showing detectable
and variable expression revealed a clear segregation pattern of the
samples. Both PCA and HCL are multivariate methods commonly
used to analyze the behaviour of multiple variables at the same
time. They are routinely used in microarray analysis to explore the
behaviour and grouping patterns of samples and genes according
to the expression data. According to both analyses, samples
obtained 7 days after spinal cord injury appeared as clearly
separate from all other samples. As illustrated in Figure 2, both the
first component of the PCA analysis and the branching pattern of
the heat map revealed a group comprising 4 out of the 5 animals
sampled at 7 days postoperation (LS7 individuals) as well as 1 LS3
individual (sampled at 3 days after injury) that are clearly separate
from all other individuals. A group consisting of predominantly
LS3 individuals could also be recognized in the heat map as well as
by the third principal component of the PCA, whereas most
untreated (control, CT) and sham individuals (SH) tended to
group together. Samples collected from animals 1 day after injury
(LS1) did not group together, either according to any PCA
component or the heat map, and these LS1 samples could not be
distinguished from those of the control or sham animals. The PCA
results also revealed that the first dichotomy between the total
samples and the LS7 samples is mostly due to the microRNA
downregulation in the LS7 samples (see file S2). The latter samples
only showed increased expression in a restricted number of
microRNAs, particularly miR-21. The presence of one LS3
individual within the LS7 group and one LS7 individual out of this
group, as well as the mixture of LS1 samples together with sham
and control individuals, does not correlate with any biological (i.e.,
BBB score) or processing (i.e., RNA, hybridization, or image
quality) variable evaluated, and we therefore assume that this
response is due to biological variations not considered in this study.
Spinal cord injury causes a progressive decrease in
microRNA expression
Expression of individual microRNAs was compared between
groups, and these results are presented in Figure 3. A paired
Student t-test followed by False Discovery Range correction
identified 763 significant changes in the studied comparisons,
affecting 343 different microRNAs (a full list is provided in file S3).
The distribution of these changes reveals that spinal cord injury
induces progressive changes in microRNA expression patterns,
which begin 3 days after injury and increase with time after
surgery (Figure 3B). This pattern results from a gradual increase in
the number of downregulated microRNAs, whereas the number of
microRNA Repression following Spinal Cord Injury
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time period (Figure 3B). MicroRNA downregulation is particularly
evident 7 days after injury, which is in agreement with the results
from the PCA and HC analyses. At this 7-day time point, roughly
200 microRNAs are downregulated with respect to the control or
sham levels and also compared to the LS1 expression levels,
although there are no significant changes with respect to the LS3
levels. In contrast, the LS3 and LS1 animals revealed far less
significant changes in microRNA expression levels with respect to
those of the sham and control groups, and no significant
differences were found between control and sham individuals or
between sham individuals analyzed at different time points.
In addition to providing information regarding general
expression patterns, the above comparisons also allowed us to
identify individual microRNAs with changes in expression
following SCI. To confirm the altered expression profiles of
microRNAs identified with the t-test, we performed comparisons
between the same pairs using the non-parametric Rank Product
analysis [12]. These analyses detected fewer significant changes
than did the t-test and identified a total of only 170 changes in 88
different microRNAs. Agreement between both tests (Figure 3A)
was found for only 70 expression changes involving 53 different
microRNAs. These 53 microRNAs include members of the miR-
17-92 cluster, miR-21, or the nervous system-specific miR-124 (see
the table in file S3).
Changes in microRNA expression are reflected in mRNA
profiles
MicroRNAs mediate the post-transcriptional regulation of gene
expression, and there is an inverse correlation between their
expression and that of their mRNA targets [13,14]. To confirm
the effects that the observed microRNA expression changes had
on the transcriptome, we assessed a list of microRNA targets,
according to the miRanda algorithm (available at http://www.
microrna.org/microrna/getDownloads.do) and the mRNA ex-
pression data from De Biase et al. [7]. These authors described
spinal cord gene expression patterns at different times after mild,
moderate and severe contusions. The injuries in the present study
Figure 1. Functional and morphological outcomes after injury. Recovery of locomotor function as represented by BBB scores (A) and
subscores (B) after moderate injury and sham surgical procedure. Open circles represent sham animals and closed circles represent injured animals.
(C) Representative histological images of eriochrome/cyanine-stained spinal cords from the different experimental groups. Tissue samples show the
site of impact and 0.5 cm rostral and caudal sections with a separation of 200 mm between each image.
doi:10.1371/journal.pone.0034534.g001
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Biase, according to the BBB scores. A general comparison between
these microRNA and mRNA profiles showed that the microRNA
downregulation following SCI in the present study is in parallel to
the mRNA upregulation resulting from equivalent injuries
(Figure 4).
Considering only the expression changes occurring 7 days after
SCI in the present study, 59 out of the 187 upregulated genes
following moderate and mild injuries are targets of microRNAs
that demonstrate significant expression changes relative to the
control at 7 days postoperation (dpo). A two-tailed Fisher exact test
showed that this number of microRNA targets was significantly
greater than would be expected by chance (see Table 1). This test
also demonstrated that the targets of 25 microRNAs with changes
in expression at 7 dpo from our analyses were also significantly
enriched.
To confirm this relationship, we used the methodology
proposed by Cheng and Li [15] to infer microRNA expression
changes from the mRNA expression data reported by De Biase et
al. [7] to compare these results to our data. Using the data from
these authors, the mRNAs showing significant changes in
expression after mild and moderate lesions were used to predict
the microRNAs potentially regulating these genes. According to
these analyses, up to 21 microRNAs showed altered expression
24 hours after injury, and 14 were changed at 7 dpo (Table 2). A
comparison between these identified microRNAs and those
showing expression changes in the present microarray analysis
revealed similar expression changes for miR-21 24 hours after SCI
as well as for 4 other microRNAs, namely, miR-184, miR-340-5p,
miR-369-3p and miR-466b, at 7 dpo (Table 2).
Is microRNA expression tissue- or species-specific?
MicroRNA expression is known to be tissue-specific, and it may
also be species- and strain-specific [16]. Phylogenetic variations in
microRNA expression and function may thus limit their potential
therapeutic applications. To evaluate potential phylogenetic
inconsistencies in expression, we compared our results to
published data from analyses describing microRNA expression
Figure 2. MicroRNA expression profiles after spinal cord injury. (A) Hierarchical cluster analysis and heat map, Euclidean distance and
average linkage clustering of data from individual replicates. This analysis provides a visual ordination of the samples and genes according to their
overall similarity. The colors of the heat map indicate microRNA upregulation (red) and downregulation (green). (B) PCA and scatterplot of the first
two components, showing the separation of the LS7 individuals. (C) Scatterplot of the first and third components of the PCA, showing a group of LS3
samples. All analyses were based on data from the 463 microRNAs showing variable expression (IQR.0.5). PC1, PC2, and PC3 correspond to the axis
determined by the first, second and third principal components of the PCA, respectively. These components are lineal combinations of the expression
values for each gene optimized to capture the maximum variation of the matrix. Each consecutive component is orthonormal to the previous ones
and absorbes the maximum amount of the remaining gene expression variation (AV, absorbed variation). Ls7, Ls3, Ls1, Sh1, Sh3 and Ct indicate
sample type and correspond to Lesion (Ls), Sham (Sh) and control, while the numbers 1, 3, 7 indicate the sampling time after surgery.
doi:10.1371/journal.pone.0034534.g002
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[6,17,18,19,20,21,22]. These comparisons reveal that most of
the microRNAs with the highest hybridization values in the spinal
cord from our analyses were also found in the spinal cords or
central nervous systems of rats and other vertebrates in previous
studies (see file S4). We observed major agreement between the
present results and the data from Liu et al. [6] for Sprague-Dawley
rats; of the 35 microRNAs with the highest expression levels in
Figure 3. Number of microRNA expression changes following spinal cord injury. (A) Table showing the number of expression changes
detected for the different pair comparisons performed. For each comparison, the first number (in bold type) corresponds to the number of significant
changes according to t-test analyses after FDR adjustment; the second number (in regular type) corresponds to the number of significant changes
according to the non-parametric Rank Product test; the third number (between brackets) corresponds to the changes found to be significant by both
tests. (B) Scatterplot illustrating the changes in microRNA expression after SCI. The y-axis indicates the number of up-regulated (positive axis) and
down-regulated (negative axis) microRNAs. Values were derived from the t-test analyses comparing microRNA expression levels at different times
after SCI to the corresponding sham or control data.
doi:10.1371/journal.pone.0034534.g003
Figure 4. Negative correlation between microRNA and mRNA expression changes. Graph illustrating the relationship between the
changes in microRNA and mRNA expression 7 days after injury. It clearly shows that mRNA upregulation parallels decreased microRNA expression.
Numbers of upregulated and downregulated microRNA data according to the t-tests comparing the injured and sham animals at 7 days after SCI. The
mRNA data correspond to the equivalent comparisons (mild plus moderately injured vs. sham at 7 dpo) from DeBiase et al. [7].
doi:10.1371/journal.pone.0034534.g004
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the highest expression levels from our analyses, and the other 13
(37%) were also detected but were present at lower levels.
Agreement was also observed when our data were compared to
those from other vertebrate species, although the number of
coincidences decreased. In these cases, approximately 20% of the
microRNAs detected in the spinal cords of each of these species
were not detected in the present study. These exceptions are
shown in Table 3 and include, among others, the b catenin-related
miR-200a and the cell-cycle regulator miR-663.
In contrast, microRNAs that were detected in the present study
but not in previous studies (Table 4) include the Exiqon miR-plus
probes as well as several newly released microRNAs, for which no
previous data have been published, and more interestingly, the
miR-451 cluster and miR-144, which are both important gene
regulators of erythrocyte homeostasis and cardiomyocyte ischemia
[23,24].
Expression changes were less similar between studies, even
within the same species and at the same time after injury. A
comparison between the most significant changes detected by Liu
and colleagues [6] and the present data (Table 5) shows that may
microRNAs found to have altered expression in Liu’s study were
not detected here (only 50% of the microRNAs altered at 1 dpo
and 35% of those at 7 dpo). For the remaining comparisons, most
of the observed changes identified by the current study agree with
those from Liu et al. [6] (25% at 1 dpo and 35% at 7 dpo). Some
microRNAs showed opposite trends as miR-290, which was shown
to significantly increase at 7 dpo, according to Liu’s [6] analyses,
whereas miR-290 showed a significant decrease in the present
Table 1. Enrichment of microRNA targets 7 days after SCI.
TNG UP %UP Fp-val
mRNA targets 4315 59 1.367 ,0.01
miR-103 359 7 1.950 ,0.01
miR-107 359 7 1.950 ,0.01
miR-10b 152 4 2.632 0.02
miR-128 331 8 2.417 ,0.01
miR-133a 169 4 2.367 0.03
miR-138 308 9 2.922 ,0.01
miR-145 299 6 2.007 0.02
miR-146a 268 5 1.866 0.04
miR-182 358 7 1.955 0.01
miR-185 522 8 1.533 0.03
miR-191 130 4 3.077 0.01
miR-219-2-3p 182 4 2.198 0.04
miR-300-5p 364 6 1.648 0.04
miR-325-3p 318 6 1.887 0.02
miR-329 200 5 2.500 0.01
miR-335 310 6 1.935 0.02
miR-340-5p 389 9 2.314 ,0.01
miR-342-3p 229 5 2.183 0.02
miR-352 125 4 3.200 0.01
miR-376b-3p 214 6 2.804 ,0.01
miR-382 246 6 2.439 ,0.01
miR-494 316 8 2.532 ,0.01
miR-7a 341 6 1.760 0.03
miR-96 237 5 2.110 0.02
miR-98 258 5 1.938 0.03
Total mRNAs 26379 187 0.709
The table details the 25 microRNAs showing significant target enrichment
among the mRNAs that were up-regulated 7 days after SCI according to De
Biase et al. [7]. The p-values were calculated according to Fisher’s Exact Test.
TNG: total number of genes, UP: upregulated genes; %UP: percentage of
upregulated genes; Fp-val: Fisher’s exact test p-value.
doi:10.1371/journal.pone.0034534.t001
Table 2. MicroRNAs with expression changes inferred from
the mRNA data.
miRNA p-val P.A. DPO
rno-miR-23a 0 no 1
rno-miR-23b 0 no 1
rno-miR-338 0.004 no 1
rno-miR-219-2-3p 0.014 no 1
rno-miR-494 0.015 no 1
rno-miR-181d 0.018 no 1
rno-miR-433 0.022 no 1
rno-miR-210 0.025 no 1
rno-miR-743b 0.025 no 1
rno-miR-138 0.026 no 1
rno-miR-181b 0.027 no 1
rno-miR-130a 0.027 no 1
rno-miR-21 0.03 yes 1
rno-miR-328 0.034 no 1
rno-miR-664 0.035 no 1
rno-miR-181a 0.038 no 1
rno-miR-132 0.04 no 1
rno-miR-342-3p 0.043 no 1
rno-miR-466c 0.046 no 1
rno-miR-325-3p 0.047 no 1
rno-miR-154 0.049 no 1
rno-miR-369-3p 0 yes 7
rno-miR-466b 0.01 yes 7
rno-miR-320 0.015 no 7
rno-miR-543 0.018 no 7
rno-miR-152 0.022 no 7
rno-miR-674-5p 0.023 no 7
rno-miR-500 0.027 no 7
rno-miR-340-5p 0.037 yes 7
rno-miR-210 0.039 no 7
rno-miR-19b 0.039 no 7
rno-miR-184 0.039 yes 7
rno-miR-130b 0.04 no 7
rno-miR-221 0.045 no 7
rno-miR-872 0.046 no 7
List of microRNAs with expression changes predicted from the mRNA data from
De Biase et al. [7]. All listed changes are associated with significant p-values
according to the methodology of Cheng and Li [15]. Predicted changes were
compared with the actual changes observed in the present analyses, as
indicated in the P.A. (present analysis) column. ‘‘Yes’’ corresponds to changes
observed in the present analysis, and ‘‘no’’ refers to changes that were not
identified. DPO: days post-operation.
doi:10.1371/journal.pone.0034534.t002
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in the present study, although most of followed trends were similar
to those observed by Liu and colleagues [6].
MicroRNA profiling data are consistent and reproducible
We validated the changes in the levels of the microRNAs miR-
21, miR-223, miR-146a, miR-219-5p, miR-29c, miR-468, miR-
145 and miR-107 using Q-PCR. MicroRNAs miR-21, miR-223,
miR-146a, and miR-219-5p showed significant expression changes
in our study (identified with both a t-test and a Rank Product test)
as well as in other reports [6,25]. The microRNA miR-21, which
was the most highly overexpressed microRNA at 7 dpo, has been
shown to play a role in apoptosis [26,27,28]. Similarly, we
analyzed proapoptotic miR-29c, which regulates p53-mediated
apoptosis [29], as well as miR-145 and miR-107, which belong to
the group of 25 microRNAs whose targets were significantly
enriched in the mRNA expression patterns following spinal cord
injury reported by De Biase et al. (2005). miR-468 expression was
not significantly altered in the arrays and is included here as a
methodological control. Among the microRNAs listed above, the
miR-219-5p level was within the most reduced microRNA levels
at 7 dpo from the array data. Furthermore, the microRNAs miR-
21 and miR-223 have previously been reported to be overex-
pressed in other nervous system array studies [5,25].
We validated the expression of these microRNAs using
TaqMan Real-Time PCR at 3 and 7 dpo in injured and sham
animals, and then we compared both of these expression profiles
to those from control animals (no surgery prior to RNA isolation).
We used the small RNA U87 to normalize the total RNA
expression. Figure 5 presents the correlation between the
Table 3. MicroRNAs detected at the spinal cord of different
vertebrates in previous studies [6,17,18,19,20,21,22] but not in
the present study.
miRNA rat mouse chicken medaka zebrafish
miR-108 XX
miR-128b X
miR-129 X
miR-132 XX X
miR-137 X
miR-187 XX
miR-190b XX
miR-194 X
miR-196a X
miR-200a X
miR-202 X
miR-205 X
miR-206 X
miR-210 XX
mir-213 XX
miR-216 X
miR-216b XX
miR-217 XX X
miR-221 XXX
miR-296 X
miR-298 X
miR-31 XX
miR-324-3p X
miR-324-5p X
miR-326 X
miR-328 X
miR-346 X
miR-351 X
miR-370 X
miR-373* X
miR-409-3p X
miR-423 X
miR-430 XX
miR-431 XX X
miR-433-5p X
miR-452 X
miR-454a X
miR-454b XX
miR-484 X
miR-485-5p X
miR-500 X
miR-638 X
miR-663 X
mir-7b X
miR-92 XX X X
Note that no data from Liu et al. [6] are included in the table because some
disagreements were observed among microRNAs with low expression but not
among those with high expression (see supplementary table 1 from Liu et al.).
Table 4. Spinal cord microRNAs exclusively detected in the
present study, in either control (un-operated) or sham
animals.
miRNA CT SH1 SH3 SH7
miR-1280 X XXX
miR-1308 X XXX
miR-144 X
miR-1826 X XXX
miR-1827 X XXX
miR-467e* X
miR-665 X
miR-923 X
miRPlus-E1013 X XXX
miRPlus-E1024 X XXX
miRPlus-E1078 X XXX
miRPlus-E1100 X XXX
miRPlus-E1103 X XXX
miRPlus-E1117 XX
miRPlus-E1218 X XXX
miRPlus-E1252 X XXX
miRPlus-E1253 X XXX
miRPlus-E1258 X
miRPlus-E1290 X XXX
miRPlus-F1003 X XXX
doi:10.1371/journal.pone.0034534.t004
microRNA Repression following Spinal Cord Injury
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normalized Q-PCR data.
The Q-PCR analysis from animals sacrificed at 3 days
postoperation revealed that miR-21 and miR-223 are significantly
upregulated in injured animals compared to both control and
sham animals. For the microRNAs that were downregulated at 3
dpo, miR-29c and miR-107 were significantly repressed in the
injured animals compared only to the control group, whereas
miR-219-5p was significantly downregulated in comparison to
both the control and the sham groups. For miR-146a and miR-
145, no significant variations in expression were found, although
there was a trend toward downregulation. When the changes in
expression were analyzed at 7 dpo, miR-21 and miR-146a levels
were found to be significantly increased at 7 dpo in comparison to
the control and sham groups. Similarly, miR-223 levels signifi-
cantly increased at 7 dpo compared to those of the control group
but not compared to those of the sham group. Conversely, the
expression of miR-219-5p, miR-107 and miR-29c were repressed
at 7 dpo. For miR-219-5p, miR-107 and miR-29c, there was a
strong repression in injured animals that was significant when
compared to both the control and the sham animals. The
expression level of miR-145 also showed a repression trend,
although this was not significant (Figure 5).
MicroRNAs affect several functions and pathways after
spinal cord injury
Spinal cord injury affects different biological processes and
pathways at different times after injury via changes in gene
expression. To evaluate the influence of microRNA level on these
gene expression changes, we employed two approaches based on
the Gene Set Enrichment Analysis (GSEA). The first approach
follows that of Gusev [30,31] and refers to the targets of
microRNAs that demonstrate significant changes in expression
regarding the inferred Gene Ontology (GO) terms for biological
processes. This method allows for the identification of GO terms
that are significantly altered according to the observed microRNA
expression differences between the control, sham and injured
animals. The complete list of GO terms that were significantly
enriched for each comparison and the number of microRNAs that
were involved are included in file S5. The top 10 most significantly
enriched terms for all comparisons included those related to
homeostasis, responses to endogenous stimuli, transcription and
the transmission of nerve impulses (see Table 6).
To further explore these data, we followed the method of Gusev
et al. [31] and performed a hierarchical clustering using the
comparisons as the samples and the numbers of microRNAs in
each significantly enriched GO term as the variables (the data
matrix is provided in file S5). The resulting heat map (Figure 6)
shows a pattern with distinct, well-defined groups. The graph
reveals a group located within the uppermost region (labeled
group A), which included all GO terms that were altered in
response to injury (with respect to the sham or controls),
irrespective of the time point considered, as well as those altered
between 1 and 7 days after injury. These 31 GO terms represent
biological processes related to cell migration, neurotransmitter
transport, transcription, responses to various stimuli and terms
related to cell growth and adhesion. A second group (group M),
which was located at the bottom of the heat map, included
biological processes that were exclusively altered at 1 day after
injury. These 4 GO terms are related to cell adhesion, muscle cell
migration and the protein kinase B signaling cascade. Conversely,
there was a large group of GO terms representing biological
processes (group F, 204 GO terms) that were altered at 3 or more
days after injury. This group includes GO terms related to
responses to various extracellular stimuli, the regulation of cell
death and apoptosis, negative regulation of nerve impulses, neuron
differentiation, ion homeostasis as well as other aspects of the cell
growth including cell size, proliferation, cell cycle or morphogen-
esis. Group C consisted of 54 GO terms that were altered as a
result of the same comparisons as in group F but excluded terms
corresponding to the comparison between LS3 and SH3. These
GO terms that were altered in response to middle-to-late injury
represented biological processes related to myelinization, neuro-
genesis, neuron differentiation, neuron projections, and vascular-
ization, together with more general processes such as cell motion,
cell growth and development. Group H includes GO terms that
were altered in all comparisons involving LS7 individuals (i.e., LS7
individuals compared to the control, SH7 or LS1 individuals). The
most remarkable terms represent neuron projection development,
neuron migration, synaptic transmission and plasticity, and pain
perception in addition to more general terms involving stimulus
responses, morphogenesis and the regulation of cell differentiation.
Group J includes GO terms that were altered 7 days after injury
relative to the controls and shams (either at the same time or for
each comparison) as well as the terms that were unique to the
Table 5. Comparison between the microRNA expression
changes described by Liu et al. [6] and those detected in the
present study.
Expression changes respect to control/sham
1 dpo 7 dpo
Name Liu Present Liu Present
rno-miR-130b 1.42 NE
rno-miR-146a 1.72 INC S
rno-miR-15b 1.15 DEC NS
rno-miR-17 1.74 INC NS
rno-miR-18a 2.71 NE 3.41 NE
rno-miR-200c 4.12 NE
rno-miR-206 3.26 NE
rno-miR-20a 1.69 NC
rno-miR-20b-5p 1.83 NE
rno-miR-21 1.37 INC S
rno-miR-214 2.01 INC NS
rno-miR-219-5p 21.82 DEC S
rno-miR-221 1.1 NE
rno-miR-223 3.58 INC S 3.4 INC S
rno-miR-24-2* 2.41 DEC NS
rno-miR-290 3.66 INC NS 2.96 DEC S
rno-miR-378 1.31 INC NS
rno-miR-410 21.21 NE
rno-miR-466b 3.05 DEC S
rno-miR-541 1.11 INC S
rno-miR-874 2,8 NE
Data restricted to microRNAs with significant changes in expression (2-fold or
greater) according to Liu et al. [6]. Expression levels at 1 and 7 dpo are
compared to the expression levels from control and sham individuals in the
present study and to the sham individuals in the Liu study. NE, not expressed;
INC, increase; S, significant; NS, not significant; NC, no change. Bold type
denotes agreement in significant changes between Liu’s and the present study.
doi:10.1371/journal.pone.0034534.t005
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diverse and are related to general biological processes, such as
regeneration and cell division, as well as calcium ion and stress
responses, immune responses and many others with little or no
relation to nervous tissue. Another interesting group, labeled
group K, includes terms that were altered based on the
comparisons between the LS3 and LS7 individuals relative to
the CT and sham individuals. This group includes GO terms
related to glial cell genesis and differentiation, wound healing,
regeneration, and the responses to various stimuli including
cAMP.
Similarly, we used IPA 5.0 (Ingenuity Systems, Redwood, CA)
to predict molecular networks involving the altered microRNAs,
their targets, and their related functions. The IPA analysis
identified gene interaction networks related to biological processes
(e.g., programmed cell death, organism injury, and transcriptional
activation) that were associated with the differentially expressed
microRNAs between the control and experimental groups.
Detailed information for the resulting networks obtained using
the IPA enrichment analysis is provided in file S6.
Following the IPA analysis, we observed that molecular
networks with top-ranking IPA scores were mainly those involving
PCR (left columns) and compared with the corresponding microarray data (right columns) using a correlation analysis (c.c: correlation coefficient). The
fold changes in the sham and injured experimental groups are with respect to the control group. The Q-PCR data were analyzed using a one-way
ANOVA followed by a Tukey post-test. *=p,0.05; **=p,0.01; ***=p,0.001.
doi:10.1371/journal.pone.0034534.g005
Table 6. Biological effects of the microRNA expression changes.
comparisons
GO term C1 C2 C3 C4 C5 C6
GO:0051272,positive regulation of cell motion x
GO:0010033,response to organic substance x x x x x
GO:0030335,positive regulation of cell migration x
GO:0015031,protein transport x x x
GO:0045184,establishment of protein localization x x
GO:0016337,cell-cell adhesion x
GO:0040017,positive regulation of locomotion x
GO:0007156,homophilic cell adhesion x
GO:0051270,regulation of cell motion x
GO:0048878,chemical homeostasis x x
GO:0042981,regulation of apoptosis x
GO:0006350,transcription xxxxx
GO:0015672,monovalent inorganic cation transport x
GO:0008104,protein localization xx
GO:0050670,regulation of lymphocyte proliferation x x
GO:0045449,regulation of transcription x
GO:0009719,response to endogenous stimulus x x x x x
GO:0007242,intracellular signaling cascade x x x
GO:0031644,regulation of neurological system process x x
GO:0051970,negative regulation of transmission of nerve impulse x
GO:0044057,regulation of system process x
GO:0050805,negative regulation of synaptic transmission x
GO:0010648,negative regulation of cell communication x
GO:0042698,ovulation cycle x
GO:0019228,regulation of action potential in neuron x
GO:0009725,response to hormone stimulus xx
GO:0007267,cell-cell signaling x
GO:0050767,regulation of neurogenesis xx
GO:0042592,homeostatic process xx
GO:0019226,transmission of nerve impulse xx
List of the 10 Gene Ontology biological function terms that were most significantly enriched according to the targets of microRNAs with significant expression changes,
according to the t-test analyses. The GSEA values were obtained using DAVID (http://david.abcc.ncifcrf.gov) algorithms. Comparisons are as follow: C1) Comparison
between CT and LS1; C2) CT vs LS3; C3) SH3 vs LS3; C4) CT vs LS7; C5) SH7 vs LS7; and C6) LS1 vs LS7.
doi:10.1371/journal.pone.0034534.t006
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many top-ranked biological functions and diseases were associated
with major post-injury events triggered by SCI. Hence, many
networks related to cell death, inflammation, organism injury and
nervous system development and function were generated, and the
most relevant networks are depicted in Figure 7.
We observed downregulation of microRNAs related to cell cycle
genes such as cdc42 (miR-LET7g) and ctnnb1 (miR340, miR-331),
which is consistent with many cell cycle-related genes that have
been implicated in neuronal damage after spinal cord injury [8].
We also found that other genes related to inflammation or cell
death within the same pathways were also targeted by micro-
RNAs. For example, the regulation of NF-kB activation in vivo by
PRKCZ (network 1) [32] is related to the downregulated miR-
148b, and the downregulation of miR-133b and miR-341 is
related to PTPRF (Figure 7, networks 1 and 4), the overexpression
of which induces apoptosis independently of p53 through a
caspase cascade that does not affect cell adhesion [33]. Similarly,
several downregulated microRNAs were associated with genes
participating in cell death process, such as yy1 (miR-294) [34], the
pro-apoptotic factor bim (miR-144), the pro-apoptotic blcap (miR-
294), which stimulates apoptosis independently of p53 and NF-kB
[35], and the anti-apoptotic factor Bcl-XL (miR-342) (Figure 7,
networks 1, 3 and 4). It is interesting to note that some microRNAs
found in the IPA networks have been implicated in the regulation
of inflammation and cell death pathways. Specifically, miR-Let7a,
miR-107, and miR-183 have been described as regulators of cell
death, and miR-181b and miR199 are involved in the control of
inflammation (see file S6).
Levels of chondroitin sulfate proteoglycans, which are neurite
growth inhibitors present in scars surrounding injury, increased
after SCI [36]. This increase functions to limit the regenerative
process of the spinal cord. Interestingly, in network 2, we detected
signaling components involved in extracellular matrix organiza-
tion, such as PLAU (miR-331) and CHSY1 (miR-1*, miR-330).
In addition to these findings, the expression of growth factors as
well as neuritogenic and axonal guidance molecules has also been
described in the spinal cord following denervation or nerve injury
[1]. According to the IPA networks (see Figure 7), the gene
expression of many of these factors is related to different
microRNAs, which are downregulated following SCI according
to our analyses. Specifically, BDNF is related to miR-183,
semaphorin 3 to miR-329 and miR-331, Neuritin-1/nrn1 to
miR-331 and miR-342 and Ephrin-B2/efnb2 to miR-340 and
miR-294. The expression of these molecules involved in axonal
targeting, neuronal survival and neurite outgrowth reflects the
response of the spinal cord to damage and the initiation of repair.
Discussion
MicroRNAs are small non-coding RNA molecules (18–24
nucleotides long) that regulate gene expression by interacting with
specific sequences of target mRNA or promoters [13,14]. These
post-transcriptional regulators can be tissue- and cell–specific and
Figure 6. Functional involvement of microRNAs with expres-
sion changes. A heat map of unsupervised hierarchical clustering of
all Gene Ontology (GO) categories obtained from an enrichment
analysis of the microRNAs with significant changes among groups
according to the t-test analyses. The GSEA values were obtained using
DAVID (http://david.abcc.ncifcrf.gov) algorithms. The gradient repre-
sents the percentage of microRNAs targeting each category in each
comparison. The GO terms included in each cluster (A to M) are detailed
in file S5.
doi:10.1371/journal.pone.0034534.g006
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expression profiles of distinct cellular phenotypes [37]. According
to some studies, the CNS expresses more distinct microRNAs than
any other tissue [18,38], in accordance with the roles of these
molecules in CNS development and neural function (see [39,40]
and references therein). MicroRNA dysregulation in the CNS is
associated with neurodegenerative disorders, including Alzhei-
mer’s, Parkinson’s, and Huntington’s disease, as well as traumatic
injury [37,41,42].
In this report, we describe the effects of moderate spinal cord
injury on microRNA expression at the injury site 1, 3 and 7 days
after the insult. Our analyses show that moderate SCI causes an
extended microRNA dysregulation, which affects multiple pro-
cesses that are in many cases related to secondary damage from
SCI. The observed expression changes consist mainly of increasing
Figure 7. Selected networks affected by microRNA expression changes according to Ingenuity Pathway Analysis (IPA). Each node
represents molecules (microRNAs, gene) and the biological relationship between two nodes is represented as a line. These networks include
microRNAs with expression changes obtained by comparison of the injury 7dpo group (LS7) with respectively non-injured control group
(CT)(network 1 and 2), Sham 7dpo group (SH7)(network3) and injury 1dpo (LS1) (network4). The top four functions associated with networks are (A)
Inflammatory Disease, Cell Morphology, Cellular Assembly and Organization, (B) Organismal Injury and Abnormalities, Cardiac Damage,
Cardiovascular Disease, (C) Nervous System Development and Function, Tissue Morphology, Cellular Development and (D) Cell Death, Nervous
System Development and Function, Cellular Function and Maintenance.
doi:10.1371/journal.pone.0034534.g007
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microRNAs appear to be upregulated. This pattern becomes
apparent 3 days after injury and is evident at 7 dpo, whereas few
changes are detected 1 day after injury. Progressive microRNA
dysregulations have been previously described in contusive spinal
cord injuries [6] and in the rat hippocampus following ischemia
[43]. Moreover, Strickland and colleagues [44] observed a similar
increase in the number of downregulated microRNAs up to 14
days after spinal cord injury.
Identifying the causes underlying the SCI-induced microRNA
downregulation is complex due to the heterogeneous cell
composition of the spinal cord and the multiple changes that take
place after injury. Expression changes in heterogeneous tissues
may be ascribed either to changes in gene regulation within a
given cell type or to changes in the relative abundance of the
expressing cell types [45]. The observed microRNA under-
expression cannot be directly linked to tissue loss because an
equivalent amount of RNA is hybridized to the arrays to create
comparable global microRNA hybridization signals (estimated as
the mean expression value from all microRNA probes on each
array; data not shown). After trauma, the spinal cord may
experience changes in the relative proportions of different cell
types due to the necrotic and apoptotic death of neurons and
oligodendrocytes [46,47] or to the infiltration of immune cells [2].
The death of specific cell types may explain the downregulation of
microRNAs that are associated with neurons, such as miR-124
and miR-128 [48], and those associated with oligodendrocytes,
such as miR-219, miR-138, and miR-338 [49,50]. In parallel, the
infiltration of immune cells, such as neutrophils and macrophages,
may also explain the overexpression of miR-223 after spinal cord
injury [25]. Thus, changes in the proportions of cell types present
in the spinal cord can alter the microRNA expression pattern.
However, this contribution is probably minor, as a major
contribution would result in a generalized shift in microRNA
expression rather than an extended downregulation of microRNA
expression, as was observed in our study. In fact, according to
previous studies [17,18,19,21,22], highly expressed microRNAs in
the spinal cord or the CNS, such as miR-125b, miR-29a, miR-
30b, and miR-9*, show sustained, high levels of expression before
and after injury (see file S1), suggesting an overall preservation of
the cell populations in the spinal cord. Additionally, changes in
microRNA expression in these cells may also contribute to the
observed profiles. Global microRNA downregulation as a cellular
response has been observed in cancers [51,52,53], in stimulated
effector T cells [54], and in CNS neurons after exposure to
noxious stimuli, both in vivo and in vitro [55]. Moreover, the
observed correlation between low microRNA levels and high
mRNA levels following spinal cord injury (see Figure 4) strongly
supports microRNA regulation of mRNA levels, although we
cannot rule out the effects of changes in the proportions of
different cell types. Cells can also reduce microRNA abundance by
blocking the required maturation machinery, e.g. inhibiting
DICER or DROSHA expression. Recent evidence has shown
that cancer cells [53] downregulate their microRNA network by
targeting DICER through the overexpression of the microRNAs
miR-103 and miR-107. However, this mechanism likely does not
apply to the present case because miR-103 and miR-107 appear to
be downregulated following injury, and previous studies have not
found significant changes in DICER or DROSHA expression [7].
Reduction in microRNA abundance appears to be a general
characteristic of cancer [51,52,53,56], and it is also observed in
response to noxious agents [57] and in some neuropathies [58].
MicroRNA downregulation in cancer cells induces tissue plasticity
and fosters invasive and metastatic behaviors [53]. Similarly,
global microRNA downregulation induced by DICER ablation
precludes the differentiation of neural stem cells [59,60] and the
acquisition of myelinating phenotypes in oligodendrocytes [49]. In
adult neural cells, induced microRNA reduction causes the death
of mature neurons [61] and oligodendrocytes [62], alters the
transcriptome of astrocytes such that they resemble more
immature or reactive-like states [63], and can even lead to
changes in neural plasticity associated with memory and learning
ability [64]. Thus, global microRNA downregulation may underlie
common processes observed after spinal cord injury, such as
neural and oligodendrocyte cell death and astrocyte reactive
gliosis, and may even be involved in neuronal plasticity.
We explored the functional roles of the microRNAs that are
dysregulated after SCI using different bioinformatic approaches
[30,31,65] based on the identification of Gene Ontology terms and
signaling pathways potentially regulated by co-expressed micro-
RNAs. These analyses revealed that changes in microRNA
expression affect a large group of biological functions known to
be altered following SCI [2,47], including alterations in general
processes such as transcription, cell growth, and migration.
Specific analyses of microRNA expression that demonstrated
altered expression at 3 or more days after injury indicate that these
microRNAs may regulate key processes including cell death or
apoptosis, nerve impulses, the cell cycle, wound healing, ion
homeostasis, responses to external stimuli (including the immune
response), myelinization, neural cell genesis and differentiation,
and vascularization.
Among these functions, cell death due to apoptosis or other
pathways is a hallmark of the pathophysiology of SCI [66,67].
Unlike the necrotic cell death that accompanies the primary
damage, apoptotic cell death is a gene-controlled event that is
stimulated or inhibited by a variety of regulatory factors including
several microRNAs [68]. Accordingly, our analyses suggest that
changes in the expression of approximately 20 microRNAs at 3
and 7 days after spinal cord injury are involved in the regulation of
cell death through different pathways, including those networks
identified by the IPA analysis (Figure 7). A close inspection of the
known effects of these microRNAs reveals a complex situation,
involving expression changes that could potentially simultaneously
stimulate and inhibit apoptosis (see Table 7). Apoptosis may be
stimulated by the downregulation of up to 7 protective
microRNAs as well as the upregulation of the pro-apoptotic
miR-15b microRNA at 3 days after injury. Conversely, we would
expect apoptosis to be inhibited by the downregulation of many
pro-apoptotic microRNAs together with the upregulation of
members of the miR-17-92 cluster. The effect of changes in the
expression of other microRNAs, such as members of the let7/
miR-98 family, remains controversial because they display
variable roles in apoptosis depending on the circumstances (see
Table 7). According to previously published studies, most of these
microRNAs regulate apoptosis through the p53 or AKT pathways
or by silencing key apoptosis molecules, such as caspases 3 and 9,
Fas/CD95, c-Myc, or several members of the BCL2 family of
proteins. The roles of these microRNAs in secondary cell death
should be accompanied by coherent changes in the expression of
their apoptosis-modulating targets in the spinal cord. This would
likely be the case for the observed increases in the expression of the
cell death inducers caspase 3 [69,70] and Fas [71], the expression
of which parallels the decreased expression of their regulators, the
let7/miR-98 family members miR-96 and miR-146a. Similarly,
HSP70 has been shown to demonstrate a strong increase in
expression peaking at 7 days after injury [69], which directly
matches the reduced expression of its regulator miR-1 [72].
Additionally, the overexpression of the mitochondrial superoxide
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the downregulation of its modulator miR-145 [75]. More
interestingly, the downregulation of the BCL-2-inhibiting micro-
RNAs miR-1, miR-138, and miR-148b is broadly consistent with
the increase in the number of BCL-2-positive cells present 3 days
after injury ([76]; however, see [77]), although microRNA
downregulation extends throughout the 7-day period after injury,
which is typically a time when the number of BCL-2-positive cells
is progressively reduced. Regulation of BCL-2 by miR-107 and
other microRNAs was recently discussed in a profiling study by
Liu et al. [6]. However, contrary to the current evidence, these
authors observed a miR-107 upregulation 4 hours after injury,
which they proposed should decrease BCL-2 levels and induce
apoptosis. Disagreements extend to other cell death-related
microRNAs that were reported by Liu [6] to demonstrate changes
in expression that we were not able to detect (mir-137 and miR-
672) or whose expression did not seem to change in the present
study (miR-214, miR-30-3p, miR-235-3p, and miR-674-5p). The
causes underlying these discrepancies with previous microRNA
profiling studies may be related to strain differences or, more
likely, to differences in the severity of the injury, as discussed
below.
Recent studies have provided compelling evidence that micro-
RNAs are involved in the immune response [78,79]. SCI triggers
an inflammatory response that is initiated by an alteration of the
blood-brain barrier and followed by the sequential infiltration of
various peripheral immune cells, the activation of microglia and
the subsequent induction of inflammatory pathways. According to
our functional analyses, expression changes in several microRNAs
may participate in these inflammatory events (Table 8), and they
may either be associated with the invading immune cells or the
modulation of inflammatory pathways. Upregulation of miR-223
is associated with the presence of neutrophils [25,78,79], which
transiently infiltrate the spinal cord early after injury [2]. Sustained
upregulation of this microRNA at 3 and 7 dpo could be the result
of the persistent presence of T lymphocytes and macrophages in
this area [80], although further confirmation of this hypothesis is
required. T cell infiltration could also explain the observed
upregulation of miR-142 expression, as this is a highly expressed
and cell type-specific microRNA in these immune cells [54].
Microglia and monocyte activation upon injury may also be a
consequence of the downregulation of miR-124 [81], otherwise a
well-known neuronal microRNA [82].
In addition to immune cell invasion or activation, the
inflammatory response is modulated by a vast number of
molecular immune mediators, such as cytokines (TNF-a, IL-6,
etc.) chemokines, and growth factors [2,83]. Key molecules in
these inflammatory pathways are known to be targets of
microRNAs that underwent changes in expression during our
analyses (Table 8), suggesting that microRNAs may contribute to
the regulation of the inflammatory response following SCI. For
example, the increased levels of pro-inflammatory factors such as
Table 7. Apoptosis-related microRNAs with significant changes in expression in the present study.
MicroRNA Expression Changes Targets, effects and references
Pro-apoptotic
miR-1 D3, D7 BCL-2 [117], HSP60 and HSP70 [72], IGF-1 [118,119]
miR-7 D3 EGFR regulating AKT pathway [120]
miR-15b U3 BCL-2 [121,122]
miR-29b D3 MCL-1 [123,124], activate P53 pathway [29]
miR-34 D3, D7 SIRT1 [125], BCL-2 [126],
miR-101 D7 MCL-1 [127]
miR-103/107 D7 CDK5R1 [128]
miR-138 D3, D7 BCL-2 [129]
miR-145 D7 c-Myc [130], see also [131] and [132]
miR-183 D7 PDCD4 inhibit TGF-beta-induced apoptosis by downregulation of PDCD4 [133]
miR-184 D7 AKT2 [109]
miR-204 D7 BCL-W, BIRC2 [134]
Anti-apoptotic
miR-10 D7 BIM [135,136]
miR-17-92 cluster (miR-17 & 20) U3 BIM, E2F1 protective according to [139], [140]
miR-21 U3, U7 TPM1, PTEN [148], PDCD4 [98], pro-apoptotic [149]
miR-96 D7 FOXO1 [144], CASP-3, FADD [27]
miR-125b D7 BMF [137], ERBB2, ERBB3 [138]
miR-146a U7 FAS [141], promotes survival [142]
miR-191 D7 Inhibition causes death of cancer cells [143]
Both pro-apoptotic and anti-apoptotic
Let7/miR-98 family D7 CASP-3 [145], FAS [91], BCLXL [146], c-Myc [147]
miR-133b D3, D7 CASP-9 [72], BCL-W, MCL-1 [150]
Expression changes, targets and references for the pro-apoptotic and anti-apoptotic microRNAs and those exhibiting dual roles are detailed. For each microRNA, the
expression changes in the present study are detailed in column EC (expression changes; D corresponds to downregulation and U to upregulation at the indicated dpo).
doi:10.1371/journal.pone.0034534.t007
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reduced expression of their regulators, miR125b and let7a,
respectively [85,86]. These and other pro-inflammatory cytokines
released in the injured area [47,87] induce inflammation through
the NF-kB signaling pathway, which is also highly regulated by
microRNAs [88]. In fact, our data suggest that a downregulation
of miR-9 and miR-199 may contribute to inflammation by
reducing the inhibition of NF-kB pathway genes, namely,
p50NFkB or ikkb [89,90,91]. Inflammation may also be induced
through the inhibition of anti-inflammatory pathways, such as the
inhibition of TGF-b pathway molecules pSMAD2, SMAD4, and
TGFBR2 by members of the miR-17-92 microRNA cluster [92]
or the silencing of the anti-inflammatory neuroprotective cytokine
IL-10 [93] by hsa-miR-106a [94]. Conversely, changes in
microRNA expression may reduce the activation of the inflam-
matory NF-kB Rpathway; for example, this may have occurred via
the decreased expression of miR-124 and miR-181b at 3 and 7
days after injury and the increased expression of miR-15, miR-223
and miR-146a (Table 8). Interestingly, miR-146a upregulation is
driven by NF-kB, which in turn is negatively regulated by this
microRNA [88,95]. Thus, overexpression of miR-146a at 7 dpo
may be a consequence of an increase in NF-kB on previous days
[96], which in turn may have caused the inactivation of this
pathway via a negative feedback mechanism. The inflammatory
effects of miR-21 are less clear, as they exhibit both pro- and anti-
inflammatory activities in the NF-kB pathway. MicroRNA miR-
21 targets PTEN, a negative regulator of NF-kB [97], as well as
PDCD4, which promotes NF-kB activation and inhibits the
expression of IL-10 [98,99,100].
Changes in several of these ‘‘inflammatory’’ microRNAs after
spinal cord injury have been described in previous studies.
Nakanishi et al. [5] observed similar changes in miR-223 and
miR-124 expression, which were also observed by Liu et al. [6],
and these studies also identified coincident expression changes in
miR-21, miR-146a, and miR-17, among others. These authors
proposed that changes in other microRNAs may also modulate
inflammation after SCI. In agreement with their results, we
observed the downregulation of miR-127, miR-181a, miR-411,
miR-99a, miR-34a, miR-30b, and miR-30c, which according to
Liu [6] should lead to increased inflammation. On the contrary,
other microRNAs identified by these authors, such as miR-152,
miR-214, miR-206, and miR-221, either did not show significant
expression changes or showed opposite behaviors in our analyses
(such as the downregulation of miR-1). However, the putative
roles of these microRNAs in inflammation are based on in silico
predictions and thus lack direct evidence.
Inflammation is directly related to other important processes in
SCI pathophysiology, particularly astrogliosis. Several microRNAs
involved in inflammation have also been shown to undergo
changes in expression following astrocyte activation in vitro [101],
including the upregulation of miR-146 and the downregulation of
miR-455, which is in agreement with our results. According to
Sahni et al. [102], BMP-induced downregulation of the inflam-
matory miR-21 causes GFAP overexpression and astrogliosis
following SCI. Surprisingly this microRNA clearly appeared to be
upregulated after injury in the present study as well as in previous
reports [6]. Astrocyte activation also seems to be promoted by the
upregulation of miR125b, which leads to GFAP and vimentin
overexpression and cdkn2a silencing in vitro [103]. However, mir-
125b demonstrated significant downregulation after injury in the
present study. It is possible that the changes in expression for both
mir-125b and miR-21 observed in the present study are associated
with an infiltration or a response by cell types other than
Table 8. Inflammation-related microRNAs with significant changes in expression in the present study.
MicroRNA Expression changes Targets, effects and references
Associated with immune cells
miR-124 D3, D7 In quiescent microglia [81]
miR-142 U1, U3, U7 In T-cells [54]
miR-223 U1, U3, U7 In neutrophils [151], particularly in SCI [25]
Pro-inflammatory
miR-17-92 cluster (miR-17 & 20) U3 PTEN [152], TGFBR2, pSMAD2, SMAD4 [92]
hsa-miR-106a U3 IL10 [94], microRNA not described in rats
miR-124 D3, D7 Ie ˆBZ [153]
miR-181b D7 CYLD [97]
Anti-inflammatory
let7a D7 IL-6 [85]
miR-9 D3, D7 NF-e ˆB [89,154]
miR-125b D7 TNF alpha [86]
miR-146a U7 TRAF6, IRAK1 promoting NF-e ˆB [155], induced by NF- e ˆB [95]
miR-199 D7 IKK b [90]
miR-15 U3 IKK a [156]
miR-223 U1, U3, U7 IKK a [156]
Both pro and anti-inflammatory
mir-21 U3, U7 PTEN [97] activating NF-kB; PDCD4 [98] inhibiting NF- e ˆB and promoting IL-10 [99,100]
Expression changes, targets, and references are detailed for the microRNAs associated with immune cells, with pro-inflammatory or anti-inflammatory roles, or with dual
roles. Column code abbreviations are the same as in table 6.
doi:10.1371/journal.pone.0034534.t008
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roles of these microRNAs.
In addition to deleterious processes such as inflammation and
cell death, trauma also triggers regenerative processes in the
damaged spinal cord. In fact, following injury, the spinal cord
displays an overexpression of growth factors (e.g., BDNF) and their
receptors (e.g., trkB), as well as an overexpression of axonal
guidance molecules (e.g., semaphorin 3) and extracellular matrix
proteins (e.g., decorin, lumican and collagens) [104], which may
promote cell survival and axonal regrowth. Our data provide
evidence for the downregulation of the microRNAs miR195 and
miR30a, which have been shown to target the growth factor
BDNF [105]. According to our IPA networks, the downregulation
of miR-183 could also promote BDNF expression (see Figure 7,
network 4), whereas the downregulation of miR-329 and miR-331
may induce the overexpression of sema3. Moreover, the downreg-
ulation of miR-29, which is a modulator of ECM homeostasis
[106], may induce the overexpression of key pro-regenerative
matrix molecules, such as laminin, collagen, and fibronectin.
Thus, the downregulation of each of these microRNAs may
contribute to the regenerative processes taking place in the
damaged spinal cord by promoting axonal targeting, neuronal
survival and neurite outgrowth. However, the pro-regenerative
miR-133b, which is a key determinant of the regenerative
capability of zebrafish spinal cord neurons [107], also appears to
be significantly downregulated following injury.
The profiles that were observed in the present study contrast
with those reported from previous studies. Comparing our data to
the results of Liu et al. [6], there are inconsistencies related to
nearly half of the expression changes described by these authors,
and this previous study did not observe the global microRNA
downregulation following injury that was observed here. These
differences are even more striking when our results are compared
with those of Nakanishi et al. [5]. These authors identified only 5
upregulated and 5 downregulated microRNAs following injury,
which is in clear disagreement with the hundreds of downregu-
lated microRNAs that were identified in the current study. There
are fewer differences between our study and a recent study by
Strickland et al. [44], who also observed an extensive microRNA
downregulation. Several factors may contribute to these differ-
ences. MicroRNAs exhibit species- as well as strain-specific
expression patterns [16] that may contribute to the observed
differences between studies. However, the comparisons that were
made to data from previous studies revealed a general agreement
in terms of the spinal cord expression patterns discovered for
vertebrates, suggesting that phylogenetic differences do not cause
significant changes in microRNA expression. In addition,
methodological aspects such as the injury type and severity, the
microarray procedures or the data analysis may also contribute to
such differences. Leaving aside aspects related to microarray
hybridization and data analysis, which are far beyond the scope of
this article, the injury model is likely responsible for many of the
observed differences in microRNA expression patterns. Severity
and injury type strongly determine the pathophysiology and
functional outcome of SCI [7], and these are reflected in the gene
expression pattern. In fact, according to the data from De Biase
and colleagues [7], mild and moderate contusion injuries induce a
strong increase in the number of up-regulated genes 7 days after
trauma, whereas down-regulated gene expression predominates
following severe injury. A similar conclusion was reached by
Strickland et al. [44], who reported a significant correlation
between BBB functional score and the expression levels of specific
microRNAs (miR-129-2 and miR-146a). SCI severity has been
shown to determine the timing and degree of neutrophil
infiltration [108] as well as the expression profile of miR-223
following SCI [25].
Despite extensive disagreement, several microRNAs showed
concordant changes in expression across studies; these included
the upregulation of miR-223 and miR-21 and the downregulation
of miR-124 and miR-219, which were observed in most, if not all,
of the examined studies. Moreover, the microRNAs miR-103,
miR-107, miR-133a, miR-145, mir146a and miR-98, which
presented altered expression at 7 days after SCI in both Liu’s
study [6] and ours, demonstrated significant alterations in the
expression of their targets, according to De Biase et al. [7]. The
microRNA expression changes that were observed in this study are
also in agreement with those predicted from the mRNA data of De
Biase and colleagues [7]. These analyses identified four micro-
RNAs with expression changes at 7 dpo; these included miR-340-
5p and miR-369-3p, which are both involved in proliferation and
adipogenic differentiation, as well as the proapoptotic miR-184
[109] and miR-466b. It may be surprising that only four
microRNAs out of the 35 microRNAs inferred from the changes
in gene expression levels (see Table 2) are confirmed in the present
analysis. However, according to Cheng and Li [14], one of the
advantages of the computational method employed is that the
expression changes of the target genes for a given microRNA
reflects its effective regulatory activity change rather than
expression change (since the expression level of a microRNA
may not reflect its ability to down-regulate target genes). Thus,
microRNA expression levels measured by microRNA microarrays
may reflect microRNA abundance but not the actual regulatory
activities of the mature microRNAs. However, and taking together
the experimental and probabilistic computational approaches,
these microRNAs can be highlighted as those playing a confirmed
role in this model of spinal cord injury.
In the present study, we evaluated microRNA expression
profiles using a rat contusive spinal cord injury model and
described a global, progressive downregulation of microRNA
expression following SCI, which parallels a previously observed
mRNA upregulation. The expression changes identified in this
study involved many microRNAs that had previously been
reported to fluctuate following SCI, although many discrepancies
between studies were also present. The biomathematical analysis
of these data allowed us to recognize the implications of many of
these microRNAs in the diverse biological processes triggered by
SCI. We have described several novel changes in microRNA
expression following SCI that require additional analyses for
validation and to unravel their functional roles. This study and
future analyses will contribute to furthering our knowledge of the
mechanisms regulating SCI pathophysiology.
Materials and Methods
Ethical Statement
All animal procedures were performed in accordance with the
normative R.D. 1201/2005 10-10 from the Spanish Ministry of
the Environment and the Agriculture Council of the Castilla-La
Mancha animal ethics committees and were approved by the
ethical committee at the Hospital Nacional de Paraplejicos. The
laboratory animals employed in this study were acquired and
cared for in accordance with the guidelines published in the NIH
Guide for the Care and Use of Laboratory Animals and the
principles presented in the ‘‘Guidelines for the Use of Animals in
Neuroscience Research’’ by the Society for Neuroscience. All
efforts were made to minimize suffering as well as the number of
animals used. The Approval Committee Identification Numbers
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and 42/2008.
Surgical methods and sample collection
Adult, female Wistar rats weighing approximately 200 g were
used for all experimental procedures. These animals were divided
into three distinct groups: one group without surgery prior to
extraction (control group), one group given laminectomies with
contusions (injured), and one group given only laminectomies
(sham). Injured and sham animals were sacrificed at 1, 3, and 7
days postoperation (dpo). Each group was composed of 5 animals.
Animals were anesthetized with intraperitoneal sodium pentobar-
bital at 40 mg/kg (Dolethal, Vetoquinol, Lure Cedex, France).
Contusion was performed at vertebral thoracic level 8 (T8) using
an IH Spinal Cord Impactor from Precision System and
Instrumentation, LLC, Va, which induced an impact of 200
kilodynes. Medullar fragments 1 cm long, which were centered on
the injury, were extracted after the animals were sacrificed. These
fragments were maintained in RNAlater buffer (Qiagen) until
RNA purification. A second set of animals was treated in parallel
to assess histopathology. For this purpose, the animals were
anesthetized and transcardially perfused with saline and 4%
paraformaldehyde at postoperative time points indicated above.
Spinal cord fragments were removed and embedded in O.C.T.
TM
(Tissue-Tek). Cryosections that were 20 mm thick were stained
with Eriochrome/cyanine, according to standard procedures.
RNA isolation and quality evaluation
Total RNA was extracted using the Qiazol Lysis Reagent
(Qiagen, Valen, CA, USA) and purified using the miRNeasy
isolation kit (Qiagen). The total RNA concentration was
determined by ultraviolet absorbance at 260 nm, and purity was
determined with the 260/280 and 260/230 nanometer ratios
using a NanoDrop ND 1000 spectrophotometer. RNA integrity
was determined according to the electropherogram, and the
derived RQI (RNA Quality Indicator) index values were obtained
using the Experion microcapillary electrophoresis system (Bio-
Rad). Only samples with RQI values over 7.5, i.e. those with well-
defined electropherograms, and samples with 260/280 and 260/
230 ratios between 1.8 and 2.2 were used for the subsequent
analyses.
Microarray hybridization
Total RNA from the 35 animals included in the analysis was
hybridized to miRCURY LNA
TM microRNA arrays (Exiqon)
containing probes for all microRNAs included in version 11.0 of
the Sanger mirBASE. RNA preparation, hybridization, staining,
and scanning of the microRNA arrays were performed according
to Exiqon protocols. Briefly, 1 mg of total RNA was labeled with
Hy3 dye (Exiqon) and hybridized to the miRCURY microarray in
a hybridization oven (Shel Lab, Agilent Technologies) with
rotation at 20 rpm and 65uC, using Surehyb hybridization
chambers (Agilent Technologies). Internal controls were spiked
to control for proper hybridization, washing and scanning. The
microarrays were scanned, and their signals were analyzed at the
Functional Genomics facility of the Scientific Park of Madrid using
an Axon GenePix 4000B microarray scanner (Axon Instruments)
and the Axon GenePix Pro software with the corresponding GAL
files (miRCURY LNA microRNA Array, v.11.0; hsa, mmu & rno,
Exiqon). Microarray scanning was performed within the first
6 hours after hybridization to minimize possible bleaching bias.
The resulting hybridization values were uploaded to the GEO
database (http://www.ncbi.nlm.nih.gov/geo/), where they may
be queried under accession number GSE19890. All data are
MIAME-compliant.
Microarray data analysis
Prior to each analysis, quality controls were performed on the
arrays images and data. The presence of scratches or staining or
hybridization artifacts on the arrays was assessed by visual
inspection of the images, which was complemented using
background, M, A and M vs. A plots from the marray package
in R [110]. Arrays showing significant scratches, dye problems, or
bias were discarded, and the samples were reanalyzed using new
arrays.
Microarray hybridization data stored as .gpr files by the
GenePix software were employed to estimate microRNA expres-
sion in each sample. A microRNA was considered to be expressed
when its corresponding probes showed hybridization signals 2
standard deviations above the background level. MicroRNAs were
excluded from further analyses if they were not considered present
in at least 3 individuals from at least one experimental group.
Hybridization data were normalized according to the Variance
Stabilization Normalization method proposed by Gusev [111] and
implemented in the vsn package of R. Because Exiqon
microarrays contain 4 replicates for each probe, the median of
these four values was used as the estimate of the expression value.
The median was employed to minimize the effect of anomalous
values on expression estimation.
Global microRNA expression was explored using hierarchical
clustering (HC) and the principal component analysis multivariate
techniques implemented in the application MeV vs. 4.5.1 from the
TM4 microarray software suite [112,113]. For HC, Euclidean
distance metric and average linkage clustering method were
employed.
Comparisons of the microRNA expression patterns among
groups were performed using both parametric and non-parametric
methods. First, the normalized values were filtered using the R
package Genefilter to eliminate invariant microRNAs, i.e., those with
gene expression without an interquartile range above 0.5 for all
samples. Parametric comparisons were performed using a paired
Student t-test analysis together with a Bayesian inference of
variance, according to the methods implemented in the Limma
package [114]. The Limma application allowed for the estimation
of the fold change and its significance according to the Student t-
test and the False Discovery Rate developed for multiple
hypothesis testing [115]. Non-parametric comparisons were
performed using the Rank Product test implemented in the
RankProd (v.2.8.0) package of R.
Comparisons regarding the microRNA changes in expression
related to the observed variations in their target mRNAs were
performed using lists of differentially expressed microRNAs from
the present study, and the mRNA expression profiles were
obtained from the supplementary material of De Biase et al. [7].
MicroRNA activity was studied for the list of mRNAs that
demonstrated significant changes in the injured rats after 1 or 7
days following moderate and mild contusions. The matrix
comprising the predicted binding affinity scores for all rat
microRNAs, according to the miRanda prediction algorithm,
was obtained from the miRNAMap database (http://mirnamap.
mbc.nctu.edu.tw/html/downloads.html). We first applied Fisher’s
Exact Test for each differentially regulated microRNA to
determine whether the number of differentially regulated predict-
ed target mRNAs was greater than would be expected by chance
(p,0.05). We also evaluated correlations between microRNA and
mRNA expression, according to the method developed by Cheng
and Li [15]. Statistical calculations for this approach were
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at http://homes.gersteinlab.org/people/cc59/InferMiRNA/
infermir.html).
Differentially expressed microRNAs, according to the different
comparisons and methods applied, were used to infer their
biological functions and generate molecular networks according to
the enrichment analyses of Gene Ontology (GO) terms and
Ingenuity Pathways (Ingenuity Systems, version 7.6; www.
ingenuity.com). GO analysis was conducted using the approach
proposed by Gusev [30]. Targets for microRNAs showing
significant expression changes were obtained from the miRNA-
Map database (http://mirnamap.mbc.nctu.edu.tw/html/
downloads.html). The resulting list of genes was employed to
conduct a Gene Ontology Enrichment Analysis using DAVID
bioinformatics resources (http://david.abcc.ncifcrf.gov; see [116])
using all genes in the rat genome as a background. Biological
Process and Molecular Function GO terms with FDR-corrected p-
values below 0.05 were selected. According to the methods of
Gusev [30], these sets of overrepresented GO categories were
filtered to select only those that were targeted by 100% or over
50% of the microRNAs in each comparison.
Ingenuity molecular networks and function and disease nets
were created based on the data concerning microRNA and
mRNA expression and significant expression changes identified by
previous analyses. Here, the networks represent a highly
interconnected set of molecules derived from the input data set.
Biological functions and processes were attributed to networks by
mapping the molecules in the network to functions in the
Ingenuity ontology and by performing a right-tailed Fisher’s exact
test to determine the significance (p-value) of any over-represen-
tation of proteins for a function compared to the result expected
for a random set of proteins. The top-ranked biological functions
were those with the lowest p-values.
Real-Time PCR
TaqMan Real-Time PCR with the 2
2DDCt relative quantifi-
cation method was performed using a Taq-Man 7900HT Fast
Real-Time PCR system (PE Applied Biosystems). The endogenous
control for normalization was U87 RNA, and the calibrator
sample was the average of the group controls (no surgery before
extraction). TaqMan assays containing primers and TaqMan
probes and the TaqMan microRNA Reverse Transcription kit
were provided by Applied Biosystems and were used according to
the manufacturer’s instructions. Briefly, 10 ng of total RNA was
used in the reverse transcription reaction, and approximately 2 ng
from that reaction was used for subsequent amplification. The
Real-Time reaction was performed using 5 samples per experi-
mental group, consisting of those that both were and were not
included in the arrays, and each sample was run in triplicate. The
reactions were programmed in the 9600 emulation mode, and the
steps consisted of one cycle for 10 min at 95uC, 40 cycles for
15 sec at 95uC, and one final cycle for 60 seconds at 60uC.
Supporting Information
File S1 Excel workbook containing raw, vsn normalized
and filtering microRNA expression data. The excel
workbook contains 4 worksheets. First worksheet details the
untreated hybridization raw data for all probes in the array. The
first 4 columns detail the position information of the probes in the
array (ID: identity number, Blk: array block, Col: vertical
coordinate within block, Row: horizontal coordinate within block).
Each individual is coded as its experimental group X individual
number. The second worksheet details the VSN normalized values
and the criteria used to filter undetected and invariant data. Array
and individual codes are represented as in previous spreadsheet.
Filter codes indicate D.F.: detection filter (yes=detected,
no=non-detected); IQR.0.5: variability filter (yes=probes
showing more than 0.5 interquartilic range across all individuals,
no=probes with IQR below 0.5); Both: probes that pass both
filters (yes) or not (no). The third worksheet shows the vsn
normalized values for all probes passing both filters. The forth
worksheet shows the vsn normalized data for all detected and
variant microRNA after computing the median value of the
repeated probes for each microRNA.
(XLS)
File S2 Excel worksheet detailing the loadings for each
microRNA expression value in the 3 first components
obtained after Principal Component Analysis. Analyzed
data correspond to the vsn normalized expression values of the
463 microRNA showing detectable and variable expression.
(XLS)
File S3 MicroRNA expression changes after spinal cord
injury. Excel workbook detailing the changes in microRNA
expression after SCI according to parametric (t-student plus FDR
adjustment) and non-parametric (Rank Product) methods. The
first worksheet shows all significant expression changes of the
analyzed microRNAs and comparisons (LS: injury, SH: sham,
CT: control). Comparisons as detailed in figure 3A. The second
worksheet shows the microRNAs showing significant changes in
different comparisons according to both parametric and non-
parametric tests.
(XLS)
File S4 Excel worksheet comparing the data of the
microRNA with the highest expression levels according
to our studies and from previous studies on vertebrate
microRNAs [6,17,18,19,20,21,22]. Data from the present
analysis are shown in columns 1 to 9. Columns 2 to 8 indicate the
microRNA with the highest expression in control, sham and
injured animals of the present study. Column 9 indicates the
detection (P) or not (A) of the different microRNA in our
microarray analysis.
(XLS)
File S5 Excel worksheet detailing the enriched GO
terms targeted by miRNA with significant expression
changes across comparisons. The first worksheet (Enriched
GO terms) details the significantly enriched GO terms for all
comparisons. The table details the probability (p) and the number
of miRNAs targeting each GO term respect to the total number of
miRNAs targeting GO terms in a particular comparison (#M).
The second worksheet (percentages matrix) shows the percentage
matrix employed in the cluster analyses. Percentages correspond to
the percentage of the total number of miRNA with significant
expression changes in a given comparison targeting a specific
GOterm. The third worksheet (clusters) details the GO terms in
the different clusters according to the hierarchical clustering
analyses (codes A to M correspond to the cluster identified in
figure 6).
(XLS)
File S6 Excel worksheet detailing the most relevant
networks associated to the present microRNA expres-
sion changes according to IPA analysis. First column details
the groups under comparison, second column describes the
functions associated to each molecular network; score denotes
the value of the IPA score (similar to the fisher exact test); and the
last column detail the set of molecules included in each network.
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Networks with comparisons in bold type are illustrated in figure 7.
(XLS)
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